Cost-effectiveness of sofosbuvir- ledipasvir for Hepatitis C treatment: a systematic review
European Journal of Clinical Pharmacology · 2026-04 · 82 (4)
DOI: 10.1007/s00228-026-04017-7 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 07.04.2026. Verfasst von Nasim Jaberi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Rashid Yasemi Street, Vali…. Hauptthemen laut MEDLINE: Fluorenes, Benzimidazoles, Antiviral Agents, Sofosbuvir. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Rashid Yasemi Street, Valiasr Street, Tehran, Iran.
- Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Rashid Yasemi Street, Valiasr Street, Tehran, Iran. khalili56@yahoo.com.
- Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Rashid Yasemi Street, Valiasr Street, Tehran, Iran, 1996713883. rezapoor_a57@yahoo.com.
Zitieren
APA
Jaberi, N., Afshari, S., Khalili, F., & Rezapour, A. (2026). Cost-effectiveness of sofosbuvir- ledipasvir for Hepatitis C treatment: a systematic review. European Journal of Clinical Pharmacology, 82(4). https://doi.org/10.1007/s00228-026-04017-7
Vancouver
Jaberi N, Afshari S, Khalili F, Rezapour A. Cost-effectiveness of sofosbuvir- ledipasvir for Hepatitis C treatment: a systematic review. European Journal of Clinical Pharmacology. 2026;82(4). doi:10.1007/s00228-026-04017-7
BibTeX
@article{Jaberi2026,
author = {Jaberi, Nasim and Afshari, Somayeh and Khalili, Farhad and Rezapour, Aziz},
title = {Cost-effectiveness of sofosbuvir- ledipasvir for Hepatitis C treatment: a systematic review},
journal = {European Journal of Clinical Pharmacology},
year = {2026},
volume = {82},
number = {4},
doi = {10.1007/s00228-026-04017-7}
}
EUVIMED